![No! Un documento dell'Ema non dice che i vaccini contengono prodotti non destinati all'uso umano - Open No! Un documento dell'Ema non dice che i vaccini contengono prodotti non destinati all'uso umano - Open](https://static.open.online/wp-content/uploads/2021/12/disinformazione-documento-pfizer-ema-vaccini-uso-umano-prodotto.jpg)
No! Un documento dell'Ema non dice che i vaccini contengono prodotti non destinati all'uso umano - Open
![Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells | Molecular Pharmaceutics Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00033/asset/images/large/mp2c00033_0004.jpeg)
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells | Molecular Pharmaceutics
![A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine - Saadati - 2022 - Chemistry – A European Journal - Wiley Online Library A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine - Saadati - 2022 - Chemistry – A European Journal - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/103d3791-8623-48c7-9d24-4b004c517bde/chem202200906-fig-5001-m.jpg)
A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine - Saadati - 2022 - Chemistry – A European Journal - Wiley Online Library
![Palli Thordarson on Twitter: "The synthesis of the Acuitas lipids is described in the patent linked below. ALC-0315 seems to be lipid III-3 in this patent and if so, the synthesis proceeds Palli Thordarson on Twitter: "The synthesis of the Acuitas lipids is described in the patent linked below. ALC-0315 seems to be lipid III-3 in this patent and if so, the synthesis proceeds](https://pbs.twimg.com/media/EpMyXJRU0AM7Rwc.jpg)
Palli Thordarson on Twitter: "The synthesis of the Acuitas lipids is described in the patent linked below. ALC-0315 seems to be lipid III-3 in this patent and if so, the synthesis proceeds
![Molecules | Free Full-Text | Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy Molecules | Free Full-Text | Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy](https://pub.mdpi-res.com/molecules/molecules-27-01943/article_deploy/html/images/molecules-27-01943-g004.png?1647512236)